News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
There has been a long controversy over intra-arterial chemo for retinoblastoma – Guillermo Chantada
Photo of Guillermo Chantada from austral.edu.ar
Aug 8, 2023, 17:53

There has been a long controversy over intra-arterial chemo for retinoblastoma – Guillermo Chantada

There has been a long controversy over intra-arterial chemo for retinoblastoma. A randomized study showed what many of us would have predict. Superior and less toxic. And the study was done in LMIC.

For the article: Click here
Source: Guillermo Chantada / Twitter

cancer chemotherapy Guillermo Chantada intra-arterial LMIC OncoDaily Oncology Retinoblastoma
Special Coverage
Blog
May 3, 2025, 10:35
Michael Baumann Honored with Jens Overgaard Legacy Award at ESTRO 2025
Blog
May 3, 2025, 10:19
Kristin Flanary Advocates for Conquer Cancer Day and Research Funding
Blog
May 3, 2025, 09:48
Robbie Beckert will present Award-Winning Research on Adaptive Radiotherapy at ESTRO 2025
Blog
May 3, 2025, 09:07
Miriam Mutebi: Cooking can serve as a therapeutic activity, promoting mental wellness and reducing stress
Blog
May 3, 2025, 09:06
Dirk Verellen Honored with Emmanuel van der Schueren Award at ESTRO 2025
Opinion
May 3, 2025, 08:36
SKAGEN Trial 1 at ESTRO 2025: Moderately Hypofractionated RT Safe, But Mortality Signal Warrants Caution
Blog
May 3, 2025, 08:03
Ruzanna Papyan: Julia Hoveyan on Access to Novel Therapies in the POEM Region at 4th POEM Scientific Meeting
Societies
May 3, 2025, 07:43
HYPO-RT-PC Phase III trial: Two-Week Radiotherapy Proven as Safe and Effective as Eight-Week Course for Prostate Cancer, After 10-Year Follow-Up
Blog
May 3, 2025, 06:07
Icro Meattini: Challenges and Opportunities of Biomarker-Directed Optimisation of Breast Radiotherapy at ESTRO25
Blog
May 3, 2025, 06:03
Joint ESTRO-EORTC Session at ESTRO25
Insight
May 3, 2025, 05:42
FAST-Forward trial 10-year results from ESTRO 2025: Hypofractionated breast radiotherapy for 1 vs 3 weeks
Blog
May 3, 2025, 05:16
Pierre Blanchard: Early Toxicity Results from GETUG Adjuvant Radiotherapy Trial after Cystectomy for Bladder Cancer